Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity

Abstract

BackgroundImmunosuppressive extracellular adenosine is generated by the enzymatic activity of CD73. In preclinical models, antibodies (Abs) targeting different epitopes on CD73 exert anticancer activity through distinct mechanisms such as inhibition...